About Us
PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF), is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat neuropsychiatric, neurodegenerative and pain disorders.
Our team includes world-class strategic partners, advisors and a strong leadership team with a proven track record
of success in drug development, business development and capital markets. Our goal is to advance the development
of panaceAI™, our drug repurposing artificial intelligence platform, and advance our clinical product pipeline
with ketamine and psilocybin in Parkinson’s disease, depression, traumatic brain injury and stroke.
of success in drug development, business development and capital markets. Our goal is to advance the development
of panaceAI™, our drug repurposing artificial intelligence platform, and advance our clinical product pipeline
with ketamine and psilocybin in Parkinson’s disease, depression, traumatic brain injury and stroke.
Our team includes world-class strategic partners, advisors and a strong leadership team with a proven track record of success in drug development, business development and capital markets. Our goal is to advance the development of panaceAI™, our drug repurposing artificial intelligence platform, and advance our clinical product pipeline with ketamine and psilocybin in Parkinson’s disease, depression, traumatic brain injury and stroke.
Connect With Us
PharmaTher Holdings Ltd.
82 Richmond Street East
Toronto, Ontario Canada
M5C 1P1
82 Richmond Street East
Toronto, Ontario Canada
M5C 1P1
